TP53 and hepatocellular carcinoma: Moreover, we compared the growth potential of different p53-null HCC lines after OTUD7B knockdown including Hep3B cells with endogenous loss of p53 or HepG2 and SMMC-7721 rendered p53 null using CRISPR-Cas9.